The Xyrem® Risk Management program

Sodium oxybate, also known as gamma-hydroxybutyric acid (GHB), was discovered in 1960 and has been described both as a therapeutic agent with high medical value and, more recently, a substance of abuse. The naturally occurring form of this drug is found in various body tissues but has been studied m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2004-01, Vol.27 (5), p.293-306
Hauptverfasser:	FULLER, David E, HORNFELDT, Carl S, KELLOWAY, Judy S, STAHL, Pamela J, ANDERSON, Todd F
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Biological and medical sciences Drug and Narcotic Control - legislation & jurisprudence Drug and Narcotic Control - organization & administration Drug Utilization Humans Illicit Drugs - legislation & jurisprudence Illicit Drugs - supply & distribution Medical sciences Miscellaneous Neuropharmacology Pharmacology. Drug treatments Product Surveillance, Postmarketing Risk Management - legislation & jurisprudence Risk Management - organization & administration Sodium Oxybate - administration & dosage Sodium Oxybate - supply & distribution Sodium Oxybate - therapeutic use United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!